IFP Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
IFP Advisors's FLXN Position: Q4 2021 in Review
IFP Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 56 shares — an estimated $1K sold.
IFP Advisors first reported a position in FLXN in Q3 2016 and held it in 11 quarters. The position peaked at $225K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- IFP Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- IFP Advisors sold 56 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1K.
- IFP Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 11 quarters.
- IFP Advisors's Flexion Therapeutics, Inc. position peaked at $225K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.